Figure 1.
CK-18 fragments are significantly higher in the serum with NASH compared to patients with non-NASH.
The vertical axis represents serum CK-18 levels in U/L, whereas the horizontal axis refers to patient groups. The box and bars represent the interquartile range (the 25th and 75th percentiles) from the median (the horizontal line) and the 95% confidence interval, respectively. CK-18 fragments levels significantly increased in patients with NASH compared to non-NASH patients (median (Q25, Q75): 372.9 U/L (319.6, 431.4), 248.1 U/L (237.5, 266.6), respectively; P < 0.001).
Figure 2.
The model receiver operating characteristic (ROC) curve for the definitive NASH diagnosis in NAFLD patients.